“Defa Life ailesinin üyesi olmanın gururu içindeyiz.”

Kimdir


ÖZGEÇMİŞİ
1987 yılında (Şereflikoçhisar) Ankara’da doğdu. 2012 yılında Gazi Üniversitesi Tıp Fakültesi’nden mezun oldu. 2017 yılında Bursa Uludağ Üniversitesi Tıp Fakültesi’nde İç Hastalıkları (Dahiliye) ihtisasını tamamladı. İç Hastalıkları Yandal Uzmanlık sınavında (2016 YDUS) Endokrinoloji ve Metabolizma Hastalıkları’nı kazandı. 2021 yılında Ankara Dışkapı Eğitim ve Araştırma Hastanesi’nde Endokrinoloji ihtisasını tamamladı. Özel Defa Life Hastanesi’nde Endokrinoloji Birimi’nde hizmet vermektedir.<\p>

  • 2012-2017 Bursa Uludağ Üniversitesi (İç Hastalıkları Asistanlığı)
  • 2017-2017 Şanlıurfa Mehamet Akif İnan EAH (İç Hastalıkları Uzmanı)
  • 2017-2018 Ankara Numune Eğitim ve Araştırma Hastanesi (Endokrinoloji Asistanlığı)
  • 2018-2021 Ankara Dışkapı Eğitim ve Araştırma Hastanesi (Endokrinoloji Asistanlığı)
  • 2021-2023 Kilis Prof. Dr. Alâeddin Yavaşça Devlet Hastanesi (Endokrinoloji Uzmanı)
  • 2023-Gaziantep Özel Defa Life Hospital Hastanesi (Endokrinoloji Uzmanı)

1. Düğer H, Bostan H, Deryol HY, İmga NN, Uçan B, Çalapkulu M, Hepşen S, Akhanlı P, Gül Ü, Sencar ME, Çakal E, Özdemir Ş, Kızılgül M. Paradoxical GH increase during oral glucose load may predict overall remission in acromegalic patients. Growth Horm IGF Res. 2022 Dec;67:101501. doi: 10.1016/j.ghir.2022.101501.

2. Düğer H, Kızılgül M, Akhanlı P, Çalapkulu M, Bostan H, Hepşen S, Gül Ü, Sencar ME, Çakal E, Uçan B. The role of elastography in the assessment of thyroid nodules in acromegaly. Turk J Med Sci. 2023 Feb;53(1):303-309. doi: 10.55730/1300-0144.5585.

3. Düğer H, Bostan H, Gül Ü, Uçan B, Hepşen S, Sakız D, Akhanlı P, Çakal E, Kızılgül M. The importance of hypophosphatemia in the clinical management of primary hyperparathyroidism. J Endocrinol Invest. 2023 Sep;46(9):1935-1940. doi: 10.1007/s40618-023-02064-w. Epub 2023 Mar 16. PMID: 36929458.

4. Düğer H, Uçan B, Çalışkan M, Bostan H, Demirci T, Gül Ü, Çakal E, Kızılgül M. Hypomagnesemia may be associated with symptomatic disease in patients with primary hyperparathyroidism. Endocrine. 2023 Nov 3.

5. Kizilgul M, Duger H, Nasiroglu NI, Sencar E, Hepsen S, Akhanli P, Berker D, Cakal E, Bostan H, Ucan B. Efficacy of cabergoline add-on therapy in patients with acromegaly resistance to somatostatin analogs treatment and the review of literature. Arch Endocrinol Metab. 2022 May 25;66(3):278–85. doi: 10.20945/2359-3997000000481.

6. Bostan H, Duger H, Akhanli P, Calapkulu M, Turkmenoglu TT, Erdol AK, Duru SA, Sencar ME, Kizilgul M, Ucan B, Ozbek M, Cakal E. Cushing’s syndrome due to adrenocorticotropic hormone-secreting metastatic neuroendocrine tumor of unknown primary origin: a case report and literature review. Hormones (Athens). 2022 Mar;21(1):147-154. doi: 10.1007/s42000-021-00316-z.

7. Ucan B, Kizilgul M, Karci AC, Duger H, Erkam Sencar M, Imga NN, Demirci T, Berker D, Erman Cakal. The prevalence of cancer and its relation to disease activity in patients with acromegaly: two centers’ experience. Endocr Pract. 2021 Jan;27(1):51-55. doi: 10.4158/EP-2020-0398. Epub 2020 Nov 18. PMID: 33475501.

8. Uçan B, Şahin M, Önal B, Kızılgül M, Düğer H, Sencar ME, Çakal E, Özbek M. Assessment of diagnostic value of preoperative elastography in thyroid nodules having indeterminate cytology results. Turk J Med Sci. 2021 Dec 13;51(6):2924-2930. doi: 10.3906/sag-2101-246.

9. Sencar ME, Hepsen S, Çalapkulu M, Bostan H, Sakiz D, Ozturk Unsal I, Duger H, Kizilgul M, Ucan B, Taskin Turkmenoglu T, Ozbek M, Cakal E. The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology. Bosn J Basic Med Sci. 2022 Feb 1;22(1):118-123. doi: 10.17305/bjbms.2021.5756.

10. Sencar ME, Calapkulu M, Sakiz D, Akhanli P, Hepsen S, Duger H, Unsal IO, Kizilgul M, Cakal E. The contribution of ultrasonographic findings to the prognosis of subacute thyroiditis. Arch Endocrinol Metab. 2020 May-Jun;64(3):306-311. doi: 10.20945/2359-3997000000253.

11. Kızılgül M, Bayır Ö, Uçan B, Akhanlı P, Düğer H, Sencar ME, Kertmen H, Yılmazer D, Yazılıtaş D, Saylam G, Korkmaz MH, Çakal E. Metastatic diffuse follicular variant papillary thyroid cancer without cervical lymph node metastasis presenting with symptoms related to hypopituitarism. Einstein (Sao Paulo). 2023 Jul 21;21:eRC0229. doi: 10.31744/einstein_journal/2023RC0229.

12. Kizilgul M, Karakis R, Dogan N, Bostan H, Yapici MM, Gul U, Ucan B, Duman E, Duger H, Cakal E, Akin O. Real-time detection of acromegaly from facial images with artificial intelligence.
Eur J Endocrinol. 2023 Jan 10;188(1):lvad005. doi: 10.1093/ejendo/lvad005.

13. Hepşen S, Akhanlı P, Düğer H, Çalapkulu M, Uçan B, Sencar ME, Sakız D, Ünsal İÖ, Bayram SM, Özbek M, Çakal E. Fatty acid-binding protein-4 as a biomarker predicting acromegaly-associated diabetes mellitus. Turk J Med Sci. 2021 Oct;51(5):2592-2599. doi: 10.3906/sag-2011-317.

14. Hepsen S, Akhanli P, Sencar ME, Duger H, Sakiz D, Kizilgul M, Ozturk Unsal I, Ucan B, Ozbek M, Cakal E. The Evaluation of Low- and High-Dose Steroid Treatments in Subacute Thyroiditis: A Retrospective Observational Study. Endocr Pract. 2021 Jun;27(6):594-600. doi: 10.1016/j.eprac.2020.11.009.

15. Hepsen S, Sakiz D, Pamukcu HE, Arslan IE, Duger H, Akhanli P, Sencar ME, Unsal IO, Ucan B, Kizilgul M, Cakal E. The Assessment of Ventricular Arrhythmia Indicators Based on Electrocardiography in Patients With Differentiated Thyroid Cancer Followed Up With Levothyroxine Suppression. Angiology. 2021 Aug;72(7):657-663. doi: 10.1177/0003319721993343.

16. Çalapkulu M, Sencar ME, Unsal IO, Sakiz D, Duger H, Özbek M, Çakal E. Tumor Volume Can Be Used as a Parameter Indicating the Severity of Disease in Parathyroid Cancer. Endocr Pract. 2021 Jul;27(7):706-709. doi: 10.1016/j.eprac.2021.01.006.

17. Çalapkulu M, Kızılgül M, Sencar ME, Düğer H, Uçan B, Çakal E, Özbek M. Avascular necrosis of the femoral head due to low-dose corticosteroid used in a patient with panhypopituitarism: A case report and literature review. Jt Dis Relat Surg. 2020;31(2):390-394. doi: 10.5606/ehc.2020.72773.

18. Calapkulu M, Sencar ME, Sakiz D, Duger H, Ozturk Unsal I, Ozbek M, Cakal E. The prognostic and diagnostic use of hematological parameters in subacute thyroiditis patients. Endocrine. 2020 Apr;68(1):138-143. doi: 10.1007/s12020-019-02163-w.

19. Calapkulu M, Sencar ME, Duger H, Bayram SM, Unsal IO, Cakal E, Ozbek M. Coexistence of Type-1 Diabetes Mellitus and Papillary Thyroid Carcinoma. Curr Diabetes Rev. 2020;16(7):787-789. doi:

20. Bostan H, Sencar ME, Calapkulu M, Hepsen S, Akhanli P, Duger H, Ucan B, Kizilgul M, Ozturk Unsal I, Ozbek M, Cakal E. The predictive value of hematologic parameters in the risk of thyroid malignancy in cases with atypia/follicular lesion of undetermined significance. Eur Arch Otorhinolaryngol. 2022 Aug;279(8):4077-4084. doi: 10.1007/s00405-021-07248-9.

21. Bostan H, Sencar ME, Calapkulu M, Hepsen S, Duger H, Ozturk Unsal I, Ozbek M, Cakal E. Two Important Issues in Subacute Thyroiditis Management: Delayed Diagnosis and Inappropriate Use of Antibiotics. Eur Thyroid J. 2021 Jul;10(4):323-329. doi: 10.1159/000513745.

22. Akhanlı P, Hepşen S, Uçan B, Düğer H, Bostan H, Kızılgül M, Sencar ME, Çakal E. The evaluation of breast findings detected through different visualisation techniques in acromegaly patients — a retrospective study. Turk J Med Sci. 2021 Dec 13;51(6):3073-3081. doi: 10.3906/sag-2105-35.